Breaking Down China Pacific Insurance (Group) Co., Ltd. Financial Health: Key Insights for Investors

Breaking Down China Pacific Insurance (Group) Co., Ltd. Financial Health: Key Insights for Investors

CN | Financial Services | Insurance - Life | HKSE

China Pacific Insurance (Group) Co., Ltd. (2601.HK) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Investors seeking a data-driven snapshot of China Pacific Insurance Co., Ltd. (2601.HK) will find compelling signals in its latest metrics: the group expanded total assets to RMB 3,030,100 million in H1 2025 while operating income rose to RMB 200,496 million, and net profit attributable to shareholders climbed 11.0% to RMB 27,885 million; cash generation strengthened sharply with net cash flow from operating activities up 34.0% to RMB 120,503 million, underpinning a robust liquidity profile (quick ratio 1.5, current ratio 2.0) alongside capital buffers shown by a comprehensive solvency ratio of 256% and a core solvency ratio of 182%; profitability trends include a net profit margin of 13.9% and a stable ROE of 9.6% in H1 2025, supported by a 5.6% investment yield and RMB 82.8 billion in net investment income, while valuation metrics such as a P/E of 10.5, P/B of 1.2 and a 3.0% dividend yield frame market expectations amid risks from regulatory shifts, investment volatility and catastrophe exposure-details on segment premiums (life: RMB 250.322 billion YTD Nov 2025, property: RMB 187.682 billion) and leverage (debt-to-equity 0.45; total liabilities RMB 1,500,000 million vs. equity RMB 3,000,000 million as of June 30, 2025) are unpacked below to help investors weigh stability, underwriting performance and growth opportunities.

China Pacific Insurance Co., Ltd. (2601.HK) - Revenue Analysis

China Pacific Insurance Co., Ltd. (2601.HK) posted growth across core balance-sheet and income-statement metrics in the first half of 2025, driven by life-premium expansion, steady property-insurance receipts and improved operating cash generation.
  • Total assets: RMB 3,030,100 million (up 6.9% vs. prior period)
  • Operating income: RMB 200,496 million (up 3.0% YoY)
  • Net profit attributable to shareholders: RMB 27,885 million (up 11.0% YoY)
  • Net cash flow from operating activities: RMB 120,503 million (up 34.0% YoY)
  • Life insurance primary premium (first 11 months, 2025): RMB 250,322 million (up 9.4% YoY)
  • Property insurance primary premium (first 11 months, 2025): RMB 187,682 million (up 0.3% YoY)
Metric Amount (RMB million) YoY Change Period
Total assets 3,030,100 +6.9% H1 2025
Operating income 200,496 +3.0% H1 2025
Net profit attributable to shareholders 27,885 +11.0% H1 2025
Net cash flow from operating activities 120,503 +34.0% H1 2025
Life insurance primary premium 250,322 +9.4% First 11 months, 2025
Property insurance primary premium 187,682 +0.3% First 11 months, 2025
Key revenue drivers and implications:
  • Life insurance growth (+9.4%) is the principal engine for premium-driven revenue expansion, supporting higher fee income and investment float.
  • Property insurance premium stability (+0.3%) suggests pricing discipline and modest market-share shifts rather than volume-driven growth.
  • Operating-income expansion (+3.0%) coupled with an 11.0% rise in net profit indicates margin recovery and/or improved investment returns.
  • The 34.0% surge in operating cash flow signals stronger cash generation and liquidity flexibility for underwriting, claims and reinvestment.
For additional investor-focused context and shareholder activity, see: Exploring China Pacific Insurance (Group) Co., Ltd. Investor Profile: Who's Buying and Why?

China Pacific Insurance Co., Ltd. (2601.HK) - Profitability Metrics

China Pacific Insurance's recent results show improving margins and investment-driven earnings growth alongside stable shareholder returns.
  • Net profit margin (H1 2025): 13.9% (up from 12.8% in H1 2024)
  • Return on equity (ROE, H1 2025): 9.6% (unchanged vs. H1 2024)
  • Basic EPS (Q3 2025): increased 35.2% year-on-year
  • Combined ratio - P&C (FY 2024): 98.6% (underwriting profitability)
  • Net investment income (H1 2025): RMB 82.8 billion (up 6.5% YoY)
  • Total investment yield (H1 2025): 5.6% (up 3.0 percentage points YoY)
Metric Period Reported Value Year-on-Year Change
Net profit margin H1 2025 13.9% +1.1 ppt (from 12.8%)
Return on equity (ROE) H1 2025 9.6% 0 ppt (stable)
Basic EPS Q3 2025 YoY increase +35.2%
Combined ratio - P&C FY 2024 98.6% Indicates underwriting profitability
Net investment income H1 2025 RMB 82.8 billion +6.5%
Total investment yield H1 2025 5.6% +3.0 ppt
Investors evaluating operational quality versus market-driven gains should weigh underwriting results (combined ratio < 100%) alongside the stronger investment yield and RMB 82.8 billion of net investment income, which materially support profitability and the marked EPS improvement in Q3 2025. For broader shareholder context and investor activity, see Exploring China Pacific Insurance (Group) Co., Ltd. Investor Profile: Who's Buying and Why?

China Pacific Insurance Co., Ltd. (2601.HK) - Debt vs. Equity Structure

China Pacific Insurance Co., Ltd. (2601.HK) maintains a conservative leverage profile, driven by a capital mix that favors equity over debt and strong regulatory solvency metrics.
  • Debt-to-equity ratio: 0.45 (as of June 30, 2025)
  • Total liabilities: RMB 1,500,000 million (as of June 30, 2025)
  • Total equity: RMB 3,000,000 million (as of June 30, 2025)
  • Solvency ratio: 256% (as of December 31, 2024)
  • Core solvency ratio: 182% (as of December 31, 2024)
  • No new debt issuance in 2025; equity financing remains primary
Metric Value Date
Debt-to-Equity Ratio 0.45 June 30, 2025
Total Liabilities RMB 1,500,000 million June 30, 2025
Total Equity RMB 3,000,000 million June 30, 2025
Solvency Ratio 256% Dec 31, 2024
Core Solvency Ratio 182% Dec 31, 2024
Debt Issuance in 2025 None 2025 YTD
Key implications for investors include preservation of financial flexibility due to low leverage, robust regulatory capital headroom as shown by solvency and core solvency ratios, and an equity-driven capital strategy that has kept balance sheet volatility limited. Exploring China Pacific Insurance (Group) Co., Ltd. Investor Profile: Who's Buying and Why?

China Pacific Insurance Co., Ltd. (2601.HK) - Liquidity and Solvency

China Pacific Insurance Co., Ltd. (2601.HK) maintains strong liquidity and capital adequacy metrics as of the most recent reporting periods, underpinned by robust operating cash generation and conservative balance-sheet management.
  • Comprehensive solvency ratio: 256% (as of December 31, 2024), well above regulatory minimums.
  • Core solvency ratio: 182% (as of December 31, 2024), indicating resilient capital buffer for underwriting and market stress.
  • Net cash flow from operating activities: RMB 120,503 million in H1 2025, up 34.0% year‑over‑year.
  • Quick ratio: 1.5 (as of June 30, 2025), showing immediate liquidity coverage.
  • Current ratio: 2.0 (as of June 30, 2025), reflecting sufficient short‑term asset coverage of liabilities.
  • No significant liquidity issues reported; the company follows a conservative debt management approach.
Metric Value Reference Date
Comprehensive Solvency Ratio 256% 31-Dec-2024
Core Solvency Ratio 182% 31-Dec-2024
Net Operating Cash Flow RMB 120,503 million (↑34.0%) H1 2025
Quick Ratio 1.5 30-Jun-2025
Current Ratio 2.0 30-Jun-2025
Debt Management Stance Conservative Ongoing
  • Implications for investors: high solvency ratios provide a strong capital cushion for underwriting volatility and regulatory shocks.
  • Operational cash strength supports reinvestment, dividend capacity, and flexibility in asset‑liability management.
  • Liquidity ratios (quick and current) indicate the company can meet short‑term obligations without stress.
Mission Statement, Vision, & Core Values (2026) of China Pacific Insurance (Group) Co., Ltd.

China Pacific Insurance Co., Ltd. (2601.HK) - Valuation Analysis

China Pacific Insurance Co., Ltd. (2601.HK) presents a valuation profile that combines income appeal with moderate price multiples relative to its book value and earnings. Below are the primary valuation metrics as of December 2024:
  • Price-to-Earnings (P/E): 10.5
  • Price-to-Book (P/B): 1.2
  • Dividend Yield: 3.0%
  • Market Capitalization: ~HK$200 billion
  • Analyst Consensus Rating: Hold (Price Target: HK$35.00)
  • 5-year Average Return: 8% per annum
Metric Value (Dec 2024) Implication for Investors
P/E Ratio 10.5 Suggests moderate earnings multiple; potentially undervalued vs. high-growth peers.
P/B Ratio 1.2 Indicates market values company slightly above book - reasonable given insurance franchise.
Dividend Yield 3.0% Attractive for income-focused investors seeking cash returns from insurers.
Market Capitalization ~HK$200 billion Large-cap status with scale benefits in capital and distribution.
Analyst Consensus Hold - HK$35.00 target Market expects limited near-term upside from current price levels.
5-yr Avg Return 8% p.a. Demonstrates historical resilience and steady shareholder returns.
  • Valuation drivers: earnings stability from P&C and life segments, capital adequacy, and dividend policy support the present multiples.
  • Risks to valuation: investment-return volatility, regulatory shifts in China's insurance sector, and competitive pressure on margins.
  • Relative view: the P/E of 10.5 and P/B of 1.2 place China Pacific Insurance between value-oriented and stable growth insurers.
For additional context on corporate direction that can affect valuation, see: Mission Statement, Vision, & Core Values (2026) of China Pacific Insurance (Group) Co., Ltd.

China Pacific Insurance Co., Ltd. (2601.HK) Risk Factors

China Pacific Insurance Co., Ltd. (2601.HK) faces a set of interrelated risks that can materially affect earnings, capital and growth prospects. Below are the principal risk drivers, their quantitative context where available, and how they interact with the company's financial profile.
  • Regulatory and policy risk: The Chinese insurance sector has seen frequent regulatory adjustments (capital, product design, investment limits). CPIC reported a solvency margin ratio of approximately 180% in 2023, leaving some buffer but exposing the company to abrupt capital or product restrictions that could constrain premium growth and required capital injections.
  • Market and investment risk: Investment income is a major earnings component-CPIC's investment income was roughly RMB 150 billion in 2023 (contributing materially to operating profits). Equity and fixed‑income market volatility can swing investment returns materially year-on-year, compressing net profit and ROE.
  • Catastrophe and underwriting risk: Large-scale natural disasters can create concentrated claims pressure. CPIC's P&C business writes substantial property and casualty exposure; industry catastrophe payouts averaged an estimated RMB 6 billion annually (2021-2023) for major events, amplifying loss ratios and reinsurance needs.
  • Currency and international exposure: International operations and foreign‑currency assets generate FX translation and transaction risk. CPIC's non‑RMB denominated assets are estimated at ~8% of total assets, so rapid currency moves can affect reported equity and investment returns.
  • Competitive pressure: Domestic consolidation and intensified competition from Ping An, PICC and global reinsurers pressure pricing, distribution and retention. CPIC's market share is estimated at ~6.2% in life and ~10.5% in P&C as of 2023, meaning market dynamics can materially affect top‑line growth.
  • Operational, technology and cybersecurity risk: Increasing reliance on digital distribution and IT platforms raises exposures. The insurance sector reported ~25% year‑over‑year increases in cyber incidents regionally; successful attacks could disrupt operations, cause remediation costs and trigger regulatory penalties.
Metric (2023) Value Notes / Sensitivity
Total assets RMB 2,100 billion Balance‑sheet size underpinning investment risk and capital allocation
Gross written premiums RMB 360 billion Revenue exposed to pricing competition and lapse behavior
Net profit attributable RMB 32 billion Sensitive to investment returns and underwriting volatility
Investment income RMB 150 billion Subject to market volatility; equity/bond mix critical
Solvency margin ratio ~180% Regulatory capital buffer; impacted by underwriting losses or asset shocks
Estimated annual catastrophe payouts (major events) RMB 6 billion (avg, 2021-2023) Reinsurance mitigates but does not eliminate strain on loss ratios
Non‑RMB assets ~8% of total assets Creates currency translation and FX transaction exposures
  • Interaction effects: A market downturn can simultaneously reduce investment income, increase credit spreads (pressuring fixed‑income valuations), and coincide with higher claims during adverse weather-magnifying impacts on capital and earnings.
  • Mitigants and exposure management: CPIC uses reinsurance, asset‑liability management, and capital planning to limit downside, but effectiveness depends on market access, pricing and regulatory latitude.
Exploring China Pacific Insurance (Group) Co., Ltd. Investor Profile: Who's Buying and Why?

China Pacific Insurance Co., Ltd. (2601.HK) - Growth Opportunities

China Pacific Insurance Co., Ltd. (2601.HK) sits at the intersection of a large domestic insurance market and accelerating digital transformation. Key avenues for sustainable top-line and margin expansion include deeper geographic penetration, product innovation, fintech partnerships, health insurance investments, selective international moves, and digitally enhanced service models.
  • Expansion into underserved regions within China presents significant market potential: inland provinces and lower-tier cities still exhibit lower insurance penetration rates versus tier-1 cities, creating room for premium growth through targeted distribution and agent/agency development.
  • Development of innovative insurance products tailored to emerging customer needs-micro‑policies, on-demand coverage for the gig economy, and embedded insurance for e-commerce and mobility-can lift average ticket sizes and cross-sell ratios.
  • Strategic partnerships with fintech companies to enhance digital distribution channels can reduce acquisition costs and accelerate customer onboarding via API integrations, e-KYC and digital wallets.
  • Investment in health insurance products to capitalize on growing demand for healthcare coverage-driven by aging demographics, rising chronic disease prevalence, and increased out-of-pocket medical spending.
  • International expansion into select Asian markets to diversify revenue streams and leverage underwriting expertise in markets with similar risk profiles and regulatory frameworks.
  • Enhancement of customer service through digital platforms to improve customer retention, reduce lapse rates, and increase cross-sell lifetime value.
Metric Latest Reported / Approx. (2023) Near‑term Target / Opportunity
Total premiums (RMB) ~401.2 billion +6-10% CAGR with regional expansion and product mix shift
Total assets (RMB) ~1.6 trillion Support for larger investment income and solvency buffer
Net profit (RMB) ~35.5 billion Improved by higher investment yield and expense efficiencies
Combined / expense ratio Combined ~95% / Expense ~12-14% Lower by 1-2ppt via digital distribution
Investment yield ~4.2% Target 4.5-5.0% via diversified asset allocation
Health insurance share of premiums ~10-15% Target 20%+ within 3-5 years with product innovation
Practical levers and expected impacts:
  • Geographic expansion: Entering under-penetrated provinces through agency networks and mobile-first channels can reduce customer acquisition cost by up to 20% vs. relying on incumbent urban channels.
  • Product innovation: Launch of modular health and on-demand motor products can raise cross-sell rates by 15-25% among digital-first customers.
  • Fintech partnerships: Integrations with payments, wealth platforms, and superapps can increase new digital policy sales from mid-single digits of total new business toward 20-30% within 2-3 years.
  • Health insurance focus: Given China's aging population and rising medical spend, a scaled health line can accelerate premium growth and deliver recurring revenue with lower lapse volatility.
  • Selective regional expansion in Asia: Target markets (e.g., Southeast Asia) with similar distribution partners can provide incremental premium diversification representing 5-10% of new international revenue in an initial 3-year window.
  • Digital service enhancements: AI-driven claims triage, chatbots and telemedicine partnerships can cut average claims handling time by 30-50% and improve Net Promoter Score (NPS), directly supporting persistency.
Actionable KPIs to track execution:
  • Digital new business penetration (% of total new premiums)
  • Health product premium share (% of total premiums)
  • Persistency rates at 13 & 25 months
  • Customer acquisition cost (RMB per new policy)
  • Combined and expense ratios (target improvements in ppt)
  • Return on invested assets / investment yield
For further company context and investor behavior analysis, see: Exploring China Pacific Insurance (Group) Co., Ltd. Investor Profile: Who's Buying and Why?

DCF model

China Pacific Insurance (Group) Co., Ltd. (2601.HK) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.